Skip to main content
Caplight Logo









Therna Biosciences

Therna Biosciences

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.therna.com/

Last Round

Seed

Aug 26, 2025

Total Funding Raised

$10M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Therna Biosciences is a biotechnology company that has developed a biology-guided, AI-powered platform to design and engineer programmable RNA therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Foundation

Keywords

rna therapeuticsgenerative aidrug discoverymrnaasosirnaai drug designlab-in-the-loopfoundation modelfrontier ai labprecision medicinebiotech platformrna medicinein silico drug designbiotech partnership

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Therna Biosciences Comparables

Compare Therna Biosciences with similar companies based on industry and business-model similarity.

Therna Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Noara Therapeutics
85%
Creyon Bio
85%
Eclipsebio
82%

Therna Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedAug 26, 2025

Key People

Founding team and executive leadership

Nazli Azimi

Co-founder And Chief Executive Officer

Founding Team

Therna Biosciences Investors

Notable investors and investment history

Therna Biosciences investors
InvestorRounds
Fusion FundSeed
Pear VCSeed
AIX VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 118% MoM.

  • Aug 26, 2025

    $10M round led by AIX Ventures.

Recent news

Latest coverage and updates

  • launchesSep 15, 2026

    Therna launched Chronos on Sep 15th '26.

Therna Biosciences Filings

Explore SEC and related filing metadata, where available.

Therna Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Therna Biosciences's valuation, stock price, and market status.

Is Therna Biosciences a public or private company?

Therna Biosciences is a private company.

What is the current stock price of Therna Biosciences?

Therna Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Therna Biosciences worth (valuation)?

Valuation information for Therna Biosciences is not publicly available.

Can I buy Therna Biosciences stock?

Therna Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Therna Biosciences's last funding round?

Therna Biosciences's most recent funding round was Seed on August 26, 2025.

Who are the main investors in Therna Biosciences?

Key investors in Therna Biosciences include AIX Ventures.

Will Therna Biosciences IPO soon?

No public IPO plans have been announced for Therna Biosciences.

How can I track Therna Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Therna Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range10
Year Founded2023
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?